Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 M2D2 Holds Third Venture Competition - Orthopedic Design & Technology

M2D2 Holds Third Venture Competition

This year's focus is orthopedic.

The Massachusetts Medical Device Development Center (M2D2), in partnership with Boston-based law firm Nutter McClennen & Fish LLP and orthopedic medical technology giant Smith & Nephew Inc., is hosting the third annual new venture competition to showcase the nation’s best innovative medical device ideas by startup companies. This year’s event will focus on the fields of orthopedic reconstruction, sports medicine and trauma.

M2D2 is a joint initiative of the Lowell and Worcester campuses of the UMass (University of Massachussetts) system that helps new medical device entrepreneurs develop products from proof-of-concept to commercialization. Since its inception in 2007, more than 100 clients have been supported by the program.

This year’s competition prizes, worth a total of $50,000, include $25,000 in services from M2D2 for product development (such as engineering and prototyping), business development (business plans and market development) and medical development (clinician consultation, animal trials, etc.); the use of M2D2 laboratory space; $15,000 in legal services from Nutter McClennen & Fish LLP and $10,000 in services from Smith & Nephew.

One of last year’s winners was Little Sparrows Technologies, a company that makes Bili-Hut, a phototherapy device for jaundiced babies.

“Severe brain injury and death from neonatal jaundice is a global tragedy that should never happen,” said Donna Brezinski, M.D., founder and CEO of Little Sparrows, at an address to the Bill and Melinda Gates Foundation in 2012. “Delivery of effective phototherapy to every baby that needs it is the solution.”

The other winners were Boston, Mass.-based Cellanyx Diagnostics Inc., which is working towards providing a lab service that offers “critical prognostic information before the radical prostatectomy decision point,” according to the company website; and Burlington, Mass.-based BioSignostix, which is working on handheld, minimally-invasive diagnostic probes for specific neurological conditions that are manifestations of metabolic disorders, infectious diseases or autoimmune illnesses.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters